Advancing precision medicine
BostonGene advances molecular and immune profiling to revolutionize cancer treatment. Our AI-powered solutions provide clinicians with actionable insights, support personalized therapy decisions, expedite drug development, and improve patient outcomes. Through strategic collaborations with leading cancer centers and pharmaceutical companies, BostonGene is integrating innovative technology into oncology care.
Credentials
.webp)
.webp)
.webp)
.webp)
.webp)
Testimonials
Through BostonGene, we are utilizing multiparametric discovery and big data analytics to uncover and validate biomarkers of therapeutic response.
We look forward to using BostonGene’s technology to facilitate our work in mechanisms of cancer neoantigen recognition.
Together, we are working to identify novel biomarkers and develop next-generation therapies fora true personalized approach to cancer care.
A tumor ‘‘personality’’ test: the BostonGene Tumor Portrait serves as a roadmap to guide treatment decision-making.
Through this collaboration we look forward to utilizing data and AI to gain more insights into the biology and mechanisms of investigational therapies at the earliest stages. These data will help us to better understand their potential in certain patient populations and ultimately help advance oncology medicines for patients who need them.
BostonGene's integrated analytic and AI capabilities will provide us with crucial insights towards developing breakthrough cancer treatments.
Collaborating with BostonGene allows us to apply advanced omnimodal analytics to real-world clinical challenges. By integrating genomic, transcriptomic and immune data into a unified platform, we can identify the right patients for the right trials, uncover novel biomarkers...
Core values
BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce the overall cost of cancer care.
BostonGene’s tests reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies.
Highlights
Achievements
.webp)
Our locations
Company Headquarters
University Office Park III 95 Sawyer Road,
Suite 500 Waltham, MA 02453
T: 617-658-4545
Suite 500 Waltham, MA 02453
T: 617-658-4545
BostonGene Laboratory
100 Beaver Street, Suite 203 Waltham,
MA 02453
T: 781-552-3131
MA 02453
T: 781-552-3131
